Sanofi Pasteur, TIV + H1N1, Pediatric Population
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study
- Status
- UNKNOWN
- Phase
- PHASE4
Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study
- Status
- COMPLETED
- Phase
- PHASE4
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
- Status
- COMPLETED
- Phase
- PHASE4
Safety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
- Status
- COMPLETED
- Phase
- PHASE2
Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
- Status
- COMPLETED
- Phase
- PHASE1
Influenza Vaccine in Pregnant Women
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Inactivated Influenza Vaccine Effectiveness in Tropical Africa
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination
- Status
- COMPLETED
- Phase
- PHASE2